# US 2021/0330587 A1 · Oral sanitizer and immune support for viral and bacterial prevention

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330587 A1
- Document ID: US20210330587A1
- Status: Published application
- Kind: A1
- Application number: 17/243,520
- Filed: 2021-04-28
- Published: 2021-10-28
- Earliest claimed: 2020-04-28
- Assignees: Coviguard Corp
- Applicants: Coviguard Corp
- Inventors: LISA MARIE KAO; FRANKLIN GARCIA-GODOY
- Web page: https://patentgrep.com/patent/US20210330587A1

## CPC

- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/0078: {for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions}
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 33/30: Zinc; Compounds thereof
- A61K 36/71: Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K 36/752: Citrus, e.g. lime, orange or lemon
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/40: Cyclodextrins; Derivatives thereof
- A61P 31/14: for RNA viruses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An oral sanitizer composition with immune support for viral, bacterial and COVID-19 prevention. The oral sanitizer composition formulated into a mouthwash, a mouth rinse, a mouth strip a throat lozenge, a mouth spray, a throat spray or a nasal spray. The oral sanitizer composition being formulated with alcohol and without alcohol.

## Claims

### Claim 1

An oral sanitizer composition with immune support for viral, bacterial and COVID-19 prevention, comprising: 0% to 0.50% by weight of polysorbate 20; 0% to 10% by weight of Xylitol; 0% to 5% by weight methylated β-cyclodextrin; 0% to 10.50% by weight of vitamin C with citrus bioflavonoids; 0% to 10% by weight of sucralose; 0% to 0.10% by weight potassium sorbate; 0% to 0.006% by weight of sodium benzoate; 0% to 5% by weight of xanthan gum; 0% to 5% by weight of menthol; 0% to 5% by weight of zinc chloride; 0% 5% by weight of zinc masker; 0% to 10% by weight of FDC Green Color; and a remaining percentage by weight of water to total 100%.

### Claim 2 (depends on 1)

The oral sanitizer composition of claim 1 formulated into a mouthwash, a mouth rinse, a mouth strip or a throat lozenge.

### Claim 3 (depends on 1)

The oral sanitizer composition of claim 1 formulated into a mouth spray, a throat spray or a nasal spray.

### Claim 4 (depends on 3)

The oral sanitizer composition of claim 3, wherein the oral sanitizer composition is deliverable via a meter dose spray pump.

### Claim 5

An oral sanitizer composition with immune support for viral, bacterial and COVID-19 prevention, comprising: 0% to 0.50% by weight of potassium sorbate; 0% to 10% by weight poloxamer 407; 0% to 5% by weight of a buffering agent capable of buffering the oral sanitizer composition to a pH of 3.0 to 8.0; 0% to 10.5% by weight of a glycerin; 0% to 10% by weight of xylitol or sucralose; 0% to 0.10% by weight of zinc chloride; 0% to 0.006% by weight of FDC Green 3; 0% to 5% by weight of methylated beta cyclodextrins; 0% to 10% citrus bioflavonoids; 0% to 0.50% by weight of zinc chloride; 0% to 10% by weight of vitamin C; 0% to 25% by weight of ethanol 190 proof 98.05; 0% to 0.295% by weight of thymol; 0% to 0.1972% by weight of menthol; 0% to 0.438% by weight of methyl salicylate; 0% to 0.5663% by weight of eucalyptus oil; and a remaining percentage by weight of water to total 100%.

### Claim 6 (depends on 5)

The oral sanitizer composition of claim 5 formulated into a mouthwash, a mouth rinse, mouth strip or a throat lozenge.

### Claim 7 (depends on 5)

The oral sanitizer composition of claim 5 formulated into a mouth spray, a throat spray or a nasal spray.

### Claim 8 (depends on 7)

The oral sanitizer composition of claim 7, wherein the oral sanitizer composition is deliverable via a meter dose spray pump.
